1,400+ Ozempic Victims File Lawsuits Over Stomach Paralysis, $700K Settlements Expected in Federal Court

The Ozempic litigation landscape has exploded in 2025, with over 1,400 lawsuits now consolidated in federal court against Novo Nordisk, the manufacturer of the popular diabetes and weight-loss drug. While there isn’t a traditional class action settlement yet, individual cases are proceeding through a Multi-District Litigation (MDL) that could result in significant compensation for victims.

In January 2025 alone, 110 new lawsuits were filed – more than triple the 31 cases added in December – bringing the total to approximately 1,443 pending cases as of March 2025.

Legal experts estimate potential settlement values ranging from $400,000 to $700,000 for severe gastroparesis cases, making this one of the largest pharmaceutical litigation matters of 2025.

What Is the Ozempic Lawsuit About?

The Ozempic lawsuits center on allegations that the drug causes severe gastrointestinal injuries, particularly gastroparesis (stomach paralysis), without adequate warnings to patients and doctors.

Key Allegations Include:

• Failure to warn about gastroparesis risks
• Inadequate labeling and safety information
• Severe gastrointestinal injuries requiring hospitalization
• Vision loss (NAION – Non-Arteritic Anterior Ischemic Optic Neuropathy)
• Long-term digestive complications

Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis. Until recently, the warning label for Ozempic did not correctly notify patients or doctors about the risk of these injuries.

Understanding the Ozempic MDL: Not a Class Action

Important Clarification: There is no Ozempic class action lawsuit. An Ozempic Class Action lawsuit would be very unfortunate for victims. On February 2nd, 2024 an Ozempic lawsuit commenced in the Eastern District of Pennsylvania federal court. This is a Multi District Litigation.

Why MDL Is Better for Victims:

• Individual case evaluation and compensation
• Higher potential settlement amounts
• Personalized legal representation
• Faster case resolution process

MDL vs. Class Action: Key Differences

Multi-District Litigation (MDL):

• Each plaintiff maintains individual lawsuit
• Settlements based on specific injuries and damages
• Higher compensation potential
• Individual attorney representation

Class Action:

• All plaintiffs grouped together
• One settlement divided among all members
• Lower individual compensation
• Single lead attorney for entire class

Current Status: Federal MDL 3094 in Pennsylvania

The U.S. Judicial Panel on Multidistrict Litigation has directed the consolidation of all existing federal court Ozempic lawsuits into the Eastern District of Pennsylvania. The case is officially designated as MDL 3094 and overseen by Judge Karen Marston.

The MDL Panel found that the actions “involve common questions of fact, and that centralization in the Eastern District of Pennsylvania will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation.”

Drugs Included in the MDL

The litigation encompasses several GLP-1 receptor agonist medications:

• Ozempic (semaglutide)
• Wegovy (semaglutide for weight loss)
• Rybelsus (oral semaglutide)
• Trulicity (dulaglutide)
• Mounjaro (tirzepatide)

Ozempic Settlement Amounts: What Victims Can Expect

Based on these significant assumptions, our attorneys believe that a successful Ozempic lawsuit could have a settlement value range of $400,000 to $700,000. This is the settlement value estimate for the “top tier” Ozempic cases, which would be those in which the plaintiff suffered severe gastroparesis requiring extensive medical intervention.

Factors Affecting Settlement Value

High-Value Cases ($400,000 – $700,000):

• Severe gastroparesis requiring hospitalization
• Feeding tube placement
• Surgical interventions
• Significant weight loss and malnutrition
• Permanent digestive complications

Medium-Value Cases ($150,000 – $400,000):

• Moderate gastroparesis with ongoing symptoms
• Multiple emergency room visits
• Diagnostic procedures and treatments
• Work loss and reduced quality of life

Lower-Value Cases ($50,000 – $150,000):

• Mild gastroparesis with documented symptoms
• Medical treatment and monitoring
• Temporary digestive issues
• Limited impact on daily activities

Who Qualifies for an Ozempic Lawsuit?

Primary Eligibility Criteria

You may qualify if you:

• Took Ozempic, Wegovy, Rybelsus, Trulicity, or Mounjaro
• Developed gastroparesis or severe gastrointestinal issues
• Required medical treatment for digestive complications
• Experienced vision loss (NAION)
• Have medical records documenting your condition

Qualifying Medical Conditions

There is solid support for gastroparesis, stomach paralysis, gastrointestinal obstruction, and ileus (bowel obstruction).

Primary Conditions:

• Gastroparesis (Delayed Gastric Emptying)
• Stomach Paralysis
• Gastrointestinal Obstruction
• Ileus (Bowel Obstruction)
• NAION (Vision Loss)

Common Symptoms:

• Chronic nausea and vomiting
• Severe abdominal pain
• Bloating and early satiety
• Malnutrition and weight loss
• Hospitalization for digestive issues
• Feeding tube requirement

In one case, a patient experienced gastroparesis leading to severe vomiting. The patient was hospitalized several times for her symptoms and lost teeth due to the effects of gastric acids brought up by severe vomiting.

Timeline: Key Dates in Ozempic Litigation

August 2023: The first Ozempic stomach paralysis lawsuit was filed on Aug. 2, 2023.

February 2024: On February 2, 2024, the MDL was officially established with 55 cases had been consolidated into the MDL.

January 2025: Under the most recent Case Management Order in the Ozempic multi-district litigation (MDL), Novo Nordisk has until January 24, 2025 to file a motion to dismiss.

March 2025: Case count reaches over 1,400 lawsuits

Current Status: So far, there have been no settlements. However, the litigation is progressing rapidly through discovery and pre-trial procedures.

How to File an Ozempic Lawsuit: Step-by-Step Guide

Step 1: Document Your Medical History

• Gather all medical records related to your Ozempic use
• Collect documentation of gastroparesis diagnosis
• Compile hospital records and treatment histories
• List all medications and dosages taken

Step 2: Consult with a Qualified Attorney

• Find a lawyer experienced in pharmaceutical litigation
• Many law firms offer free case evaluations
• Discuss your specific symptoms and medical timeline
• Review potential settlement value for your case

Step 3: Case Evaluation and Filing

• Attorney reviews medical records and case strength
• Legal team files lawsuit in appropriate jurisdiction
• Case gets transferred to Pennsylvania MDL if in federal court
• Discovery process begins

Step 4: Litigation Process

• Document production and expert witness preparation
• Medical examinations and depositions
• Settlement negotiations with Novo Nordisk
• Trial preparation if settlement not reached

Legal Resources and Where to Get Help

Recommended Legal Resources

Official Court Information:

• Eastern District of Pennsylvania MDL 3094: https://www.paed.uscourts.gov/mdl/mdl-3094-re-glucagon-peptide-1-receptor-agonists-glp-1-ras-products-liability-litigation

Legal Assistance:

• TorHoerman Law: https://www.torhoermanlaw.com/ozempic-lawsuit/
• Sokolove Law: https://www.sokolovelaw.com/dangerous-drugs/ozempic/
• Lawsuit Information Center: https://www.lawsuit-information-center.com/ozempic-gastroparesis-lawsuit.html

Medical Information:

• DrugWatch: https://www.drugwatch.com/legal/ozempic-lawsuit/
• FDA Drug Safety Communications: https://www.fda.gov/drugs/drug-safety-and-availability

How to Contact an Ozempic Attorney

Free Consultation Options:

• Most pharmaceutical litigation attorneys offer free case reviews
• For over 45 years, Sokolove Law has stood up to pharmaceutical and drug companies, securing over $1.6 Billion for clients across the country.
• Call 1-866-898-3173 for immediate case evaluation
• Complete online forms for 24/7 case submission

What to Expect: Ozempic Lawsuit Timeline and Process

Current Litigation Phase (2025)

• Discovery Phase: Both sides exchanging documents and information
• Expert Witness Preparation: Medical experts analyzing causation
• Bellwether Trials: Test cases to gauge settlement values
• Settlement Negotiations: Individual case resolution discussions

Expected Timeline

• 2025: Motion to dismiss rulings and discovery continuation
• 2026: First bellwether trials likely to begin
• 2026-2027: Major settlement negotiations expected
• 2027-2028: Individual case resolutions and payouts

Recent Legal Developments and Updates

August 2025 Updates

Case Growth: Plaintiff’s lawyers expected the number could grow to as many as 10,000 cases as awareness of gastroparesis risks increases.

Defense Strategy: Defendants filed a motion to dismiss most claims, arguing that plaintiffs lack valid causes of action for fraud, negligent misrepresentation, or design defects aside from failure-to-warn allegations.

Medical Evidence: Gastroparesis (Delayed Gastric Emptying): A condition where food remains in the stomach longer than normal. Symptoms include chronic nausea, vomiting, bloating, and malnutrition. In many lawsuits, patients were hospitalized and required feeding tubes or surgical intervention.

Understanding Gastroparesis: The Core Medical Issue

What Is Gastroparesis?

Gastroparesis, also known as delayed gastric emptying, is a condition where the stomach cannot empty food normally. In Ozempic cases, this condition can become severe and life-threatening.

Symptoms of Ozempic-Related Gastroparesis:

• Persistent nausea and vomiting
• Abdominal pain and bloating
• Feeling full after eating small amounts
• Weight loss and malnutrition
• Blood sugar fluctuations
• Dehydration requiring hospitalization

Severe Complications:

• Malnutrition requiring feeding tubes
• Dental damage from chronic vomiting
• Hospitalization for dehydration
• Surgical interventions
• Permanent digestive dysfunction

FAQ: Ozempic Lawsuit and Settlement Information

Is there an Ozempic class action settlement?

No, there is no Ozempic class action lawsuit or settlement. The Ozempic Lawsuits for health problems linked to the drug are consolidated into a federal multidistrict litigation (MDL). This MDL structure typically results in higher individual compensation than class action settlements.

How much can I receive from an Ozempic lawsuit settlement?

Settlement values are estimated to range from $400,000 to $700,000 for severe gastroparesis cases, though individual amounts depend on the severity of injuries, medical expenses, and impact on quality of life.

What medications are included in the Ozempic lawsuits?

The MDL includes several GLP-1 receptor agonists: Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro. All these medications have similar mechanisms of action and alleged side effects.

How long do I have to file an Ozempic lawsuit?

Statute of limitations varies by state, typically 2-3 years from when you knew or should have known about the connection between your illness and Ozempic. Consult with an attorney immediately to protect your rights.

Do I need to have stopped taking Ozempic to file a lawsuit?

No, you don’t need to have stopped taking the medication to file a lawsuit. However, you should consult with both your doctor and attorney about the best course of action for your specific situation.

What medical records do I need for an Ozempic lawsuit?

You’ll need records showing: Ozempic prescription and usage dates, gastroparesis or GI diagnosis, hospitalization records, treatment histories, and any ongoing medical care related to digestive issues.

Will I have to pay attorney fees upfront?

Most Ozempic lawsuit attorneys work on contingency fees, meaning you pay nothing upfront and attorneys only get paid if you win your case. Typical contingency fees range from 33-40% of any settlement or award.

How is the Ozempic MDL different from a class action?

In an MDL, each plaintiff maintains their individual lawsuit and receives compensation based on their specific injuries. Class actions group everyone together with one settlement divided among all members, typically resulting in much lower individual payouts.

When will Ozempic settlements start being paid?

So far, there have been no settlements. However, legal experts expect settlement negotiations to intensify in 2026-2027 following bellwether trials that will help establish case values.

Can I file a lawsuit if I only had mild gastroparesis symptoms?

Yes, even mild gastroparesis cases may qualify for compensation, though settlement amounts will be lower than severe cases requiring hospitalization or surgical intervention. Consult with an attorney to evaluate your specific case.

What if Novo Nordisk’s motion to dismiss is successful?

Novo Nordisk has until January 24, 2025 to file a motion to dismiss. Even if some claims are dismissed, failure-to-warn claims are likely to survive, as these are the strongest legal theories in pharmaceutical litigation.

Are there any costs to participate in the Ozempic MDL?

Beyond attorney fees (paid on contingency), there may be minor costs for medical records, expert witnesses, and case expenses. Many attorneys advance these costs and deduct them from any eventual settlement.

Next Steps: Taking Action on Your Ozempic Lawsuit

Immediate Actions to Take

If You’re Currently Taking Ozempic:

• Don’t stop medication without consulting your doctor
• Document any digestive symptoms you experience
• Keep detailed records of dosages and dates
• Seek immediate medical attention for severe symptoms

If You’ve Stopped Taking Ozempic:

• Gather all medical records related to your treatment
• Document the timeline of your symptoms
• Contact a qualified pharmaceutical litigation attorney
• Don’t delay – statute of limitations may apply

Choosing the Right Attorney

Look for Law Firms With:

• Experience in pharmaceutical litigation
• Track record in MDL cases
• Resources to handle complex medical cases
• No upfront fee requirements
• National practice capabilities

Questions to Ask Potential Attorneys:

• How many Ozempic cases have you handled?
• What is your experience with MDL litigation?
• What are the estimated costs and timeline?
• How do you handle client communication?
• What are your contingency fee rates?

Conclusion: The Future of Ozempic Litigation

The Ozempic MDL represents one of the most significant pharmaceutical litigation matters of 2025, with over 1,400 cases and growing. While no settlements have been reached yet, the legal momentum is building toward substantial compensation for victims of gastroparesis and other severe side effects.

At least 55 lawsuits claiming Ozempic and other GLP-1 receptor agonist class drugs caused severe gastrointestinal injuries were combined into a federal multidistrict litigation in the Eastern District of Pennsylvania. Plaintiff’s lawyers expected the number could grow to as many as 10,000.

For individuals who have suffered gastroparesis, stomach paralysis, or vision loss after taking Ozempic or related medications, the window for legal action remains open. With potential settlement values ranging from $400,000 to $700,000 for severe cases, victims have significant financial recovery opportunities.

The key to maximizing your legal recovery is acting quickly to preserve evidence, document your medical condition, and secure experienced legal representation. As the MDL progresses through 2025 and into 2026, early case preparation will be crucial for optimal outcomes.

Remember: This litigation is not just about individual compensation—it’s about holding pharmaceutical companies accountable for adequate safety warnings and protecting future patients from preventable injuries.

Legal Disclaimer: This article provides general information about Ozempic litigation and should not be construed as legal or medical advice. Individual cases vary significantly, and potential compensation depends on specific facts and circumstances. Consult with qualified attorneys and healthcare providers for personalized guidance regarding your specific situation.

Last Updated: August 18, 2025